Harnessing Pyroptosis for Cancer Immunotherapy
Cells · 16.02.2024 · 13 (4) · 346
DOI: 10.3390/cells13040346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 16.02.2024. Verfasst von Christopher M Bourne und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Pyroptosis, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, UNCF/BMS EE Just Early Career Investigator Award and NIH R00 Career Transition, Burroughs Wellcome Fund.
Abstract (Originalsprache)
Cancer immunotherapy is a novel pillar of cancer treatment that harnesses the immune system to fight tumors and generally results in robust antitumor immunity. Although immunotherapy has achieved remarkable clinical success for some patients, many patients do not respond, underscoring the need to develop new strategies to promote antitumor immunity. Pyroptosis is an immunostimulatory type of regulated cell death that activates the innate immune system. A hallmark of pyroptosis is the release of intracellular contents such as cytokines, alarmins, and chemokines that can stimulate adaptive immune activation. Recent studies suggest that pyroptosis promotes antitumor immunity. Here, we review the mechanisms by which pyroptosis can be induced and highlight new strategies to induce pyroptosis in cancer cells for antitumor defense. We discuss how pyroptosis modulates the tumor microenvironment to stimulate adaptive immunity and promote antitumor immunity. We also suggest research areas to focus on for continued development of pyroptosis as an anticancer treatment. Pyroptosis-based anticancer therapies offer a promising new avenue for treating immunologically ‘cold’ tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Cornelius Y Taabazuing
Förderung
- NIAID NIH HHS
- UNCF/BMS EE Just Early Career Investigator Award and NIH R00 Career Transition
- Burroughs Wellcome Fund
Zitieren
APA
Bourne, C. M., & Taabazuing, C. Y. (2024). Harnessing Pyroptosis for Cancer Immunotherapy. Cells, 13(4), 346. https://doi.org/10.3390/cells13040346
Vancouver
Bourne CM, Taabazuing CY. Harnessing Pyroptosis for Cancer Immunotherapy. Cells. 2024;13(4):346. doi:10.3390/cells13040346
BibTeX
@article{Bourne2024,
author = {Bourne, Christopher M and Taabazuing, Cornelius Y},
title = {Harnessing Pyroptosis for Cancer Immunotherapy},
journal = {Cells},
year = {2024},
volume = {13},
number = {4},
pages = {346},
doi = {10.3390/cells13040346}
}
EUVIMED